Chemel AB (publ) develops, manufactures and sells biochemical analysis systems based on the SIRE® technology including instrument, reagents, service and software. The end-users are biotech and food industries. Furthermore, the company develops clinical applications, initially in the field of blood glucose analysis.
Our vision is a successful Swedish biotech company with global sales of high quality analysis products. Our goal is to be regarded as a competent and reliable provider of analysis solutions in well-defined food and bioprocess applications. Further goals involve development of clinical diagnostic tools and licensing of the SIRE® Technology in niche-areas where the company does not have the intention to explore the SIRE® Technology itself.
Chemel shall develop high quality products and offer complete solutions for user-friendly, specific, flexible and rapid analysis in complex sample solutions to its customers. The products will be marketed by Chemel itself and through well-renown distributors or other types of partners globally. The SIRE® Technology will be developed by Chemel itself or, if technically and economically favourable, together with partners.